Overview

Naltrexone in Borderline Personality Disorder

Status:
Terminated

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate whether naltrexone reduces the intensity and duration of flashbacks and dissociative states in patients with borderline personality disorder.

Phase:

Phase 3

Details

Lead Sponsor:

Central Institute of Mental Health, Mannheim

Treatments:

Naltrexone